[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100588014":3},{"organization":4,"outcomesModule":7,"designInfo":26,"detailedDescription":36,"studyPopulation":25,"armGroups":37,"interventions":50,"overallOfficials":61,"centralContacts":65,"locations":25,"responsibleParty":71,"collaborators":25,"id":74,"slug":25,"hasResults":75,"nctId":76,"briefTitle":77,"officialTitle":78,"acronym":25,"eligibilityCriteria":79,"healthyVolunteers":75,"sex":80,"minAge":81,"maxAge":25,"enrollmentInfo":82,"targetDuration":25,"studyType":85,"phases":86,"briefSummary":88,"conditions":89,"keywords":25,"overallStatus":91,"whyStopped":25,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":25},{"fullName":5,"class":6},"Shin Kong Wu Ho-Su Memorial Hospital","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":25},[9],{"measure":10,"description":11,"timeFrame":12},"Shoulder Pain and Disability Index","A questionnaire to evaluate the severity of shoulder pain and disability in patients with shoulder problems; higher scores indicated more significant pain and disability.The score ranges from 0 to 100: 0 = no disability; 100 = most severe disability","Score change from baseline to 1 week, 1 months and 3 months of treatment, higher score, the better outcome",[14,17,19,22],{"measure":15,"description":16,"timeFrame":12},"Disabilities of the Arm, Shoulder, and Hand","The questionnaire to measure physical function and symptoms in people with upper-limb disorders, including conditions affecting the shoulder, elbow, wrist, or hand. The score ranges from 0 to 100: 0 = no disability; 100 = most severe disability",{"measure":12,"description":18,"timeFrame":12},"Range of motions of shoulder joint",{"measure":20,"description":21,"timeFrame":12},"World Health Organization Quality of Life","Assesses 4 key domains: Physical Health, Psychological , Social Relationships and Environment, score ranges 0-100, higher score indicates greater health",{"measure":23,"description":24,"timeFrame":12},"visual analog scale","Measuring subjective pain intensity, score ranges from 0 to 10 (or 0 to 100 mm, depending on format), the higher score indicates more severe symptom",null,{"allocation":27,"interventionModel":28,"interventionModelDescription":25,"primaryPurpose":29,"observationalModel":25,"timePerspective":25,"maskingInfo":30},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":31,"maskingDescription":25,"whoMasked":32},"TRIPLE",[33,34,35],"PARTICIPANT","INVESTIGATOR","OUTCOMES_ASSESSOR","Evaluation indicators include pain (measured by Visual Analog Scale for rest, activity, and sleep, and pain threshold via pressure algometer), function (assessed by Disabilities of the Arm, Shoulder, and Hand score and Shoulder Pain and Disability Index), quality of life (using the World Health Organization Quality of Life-BREF).",[38,45],{"label":39,"type":40,"description":41,"interventionNames":42},"Intervention group","EXPERIMENTAL","traditional rehabilitation programs",[43,44],"Drug: Hyaluronic acid injection","Drug: Triamcinolone Acetonide injection",{"label":46,"type":47,"description":48,"interventionNames":49},"Control","ACTIVE_COMPARATOR","Hyaluronic acid injection",[43],[51,56],{"type":52,"name":48,"description":41,"armGroupLabels":53,"otherNames":54},"DRUG",[46,39],[55],"Hyaluronic acid",{"type":52,"name":57,"description":41,"armGroupLabels":58,"otherNames":59},"Triamcinolone Acetonide injection",[39],[60],"Triamcinolone Acetonide",[62],{"name":63,"affiliation":5,"role":64},"Ru-Lan Hsieh","STUDY_DIRECTOR",[66],{"name":67,"role":68,"phone":69,"phoneExt":25,"email":70},"Ru-Lan Hsieh, Dr, MD","CONTACT","886 + 2-28332211","M001052@ms.skh.org.tw",{"type":72,"investigatorFullName":63,"investigatorTitle":73,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"PRINCIPAL_INVESTIGATOR","MD","100588014",false,"NCT06935877","Additional Effect of Steroid on Hyaluronic Acid in Subdeltoid Bursitis","Comparison of the Efficacy of Combined Hyaluronic Acid and Triamcinolone Acetonide Injection and Hyaluronic Acid Alone Injection in Patients With Subdeltoid Bursitis","Inclusion Criteria:\n\n* \\- Unilateral shoulder pain within the past 3 months\n\nPain during joint movements such as abduction or internal rotation\n\nAt least one positive result from the following tests: Painful arc, Neer test, or Hawkins test\n\nNo shoulder injections received in the past 3 months\n\nWillingness to receive injection treatment and undergo follow-up assessments at the following time points:\n\nImmediate (1 week after injection)\n\nShort-term (1 month after injection)\n\nMid-term (3 months after injection)\n\nAvoid use of anti-inflammatory painkillers during the study period as much as possible; if intolerable pain occurs, acetaminophen (provided by the researcher) will be used to relieve symptoms\n\nExclusion Criteria:\n\n* Presence of infectious disease, inflammation, rheumatoid arthritis, or fracture\n\nHistory of malignancy\n\nPrevious shoulder surgery\n\nSensory deficits\n\nTendon rupture of the rotator cuff or biceps tendon\n\nNeurological disorders causing hand weakness or affecting shoulder mobility (e.g., stroke, Parkinson's disease, brachial plexus injury, peripheral neuropathy)\n\nCognitive impairment preventing completion of questionnaires\n\nCervical radiculopathy\n\nDiagnosed frozen shoulder (adhesive capsulitis)\n\nPsychiatric disorders\n\nBreastfeeding or pregnant women\n\nReceived shoulder injection within the past 3 months, including corticosteroids, hyaluronic acid, Platelet-rich plasma, or any prolotherapy solution","ALL","20 Years",{"count":83,"type":84},60,"ESTIMATED","INTERVENTIONAL",[87],"PHASE4","The study employs a double-blind, randomized clinical trial design with 60 patients diagnosed with subdeltoid bursitis. Participants are divided into two groups: the experimental group receives combined hyaluronic acid and Triamcinolone Acetonide injections, while the control group receives hyaluronic acid alone injection. All injections are guided by ultrasound. Assessments are conducted before treatment and at 1 week, 1 month, and 3 months post-treatment.",[90],"Subdeltoid Bursitis of the Shoulder","NOT_YET_RECRUITING","2025-04-20",{"date":94,"type":95},"2025-04-24","ACTUAL",{"date":97,"type":84},"2025-04-25",{"date":99,"type":84},"2026-06-30",{"name":5,"class":6}]